2.70HKD
459.81 MHKD
2.91 BHKD
27.93 M
About SHANGHAI HAOHAI BIOLOGICAL TECH CO
Sector
Industry
CEO
Jian Ying Wu
Website
Headquarters
Shanghai
Employees (FY)
2.16 K
Founded
2007
ISIN
CNE100001W69
FIGI
BBG008K6DXS9
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, production and sales of medical devices and pharmaceuticals. It offers orthopedics, medical aesthetics, wound healing, hemostasis, ophthalmology and anti-adhesion products. The company mainly offers intraocular lens (IOL), ophthalmology and optometry end products, medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF amd other related products. Shanghai Haohai Biological Technology was founded on January 24, 2007 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6826 is 38.90 HKD — it has increased by 1.97% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANGHAI HAOHAI BIOLOGICAL TECH CO stocks are traded under the ticker 6826.
SHANGHAI HAOHAI BIOLOGICAL TECH CO is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
6826 stock is 5.07% volatile and has beta coefficient of 1.04. Check out the list of the most volatile stocks — is SHANGHAI HAOHAI BIOLOGICAL TECH CO there?
One year price forecast for SHANGHAI HAOHAI BIOLOGICAL TECH CO has a max estimate of 124.55 HKD and a min estimate of 103.65 HKD.
SHANGHAI HAOHAI BIOLOGICAL TECH CO revenue for the last quarter amounts to 758.62 M HKD despite the estimated figure of 724.04 M HKD. In the next quarter revenue is expected to reach 739.29 M HKD.
Yes, you can track SHANGHAI HAOHAI BIOLOGICAL TECH CO financials in yearly and quarterly reports right on TradingView.
6826 stock has fallen by 2.75% compared to the previous week, the month change is a 6.49% fall, over the last year SHANGHAI HAOHAI BIOLOGICAL TECH CO has showed a 9.01% decrease.
6826 net income for the last quarter is 96.55 M HKD, while the quarter before that showed 131.25 M HKD of net income which accounts for −26.44% change. Track more SHANGHAI HAOHAI BIOLOGICAL TECH CO financial stats to get the full picture.
Today SHANGHAI HAOHAI BIOLOGICAL TECH CO has the market capitalization of 6.39 B, it has decreased by 4.10% over the last week.
SHANGHAI HAOHAI BIOLOGICAL TECH CO dividend yield was 2.48% in 2023, and payout ratio reached 37.09%. The year before the numbers were 1.20% and 36.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 6826 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI HAOHAI BIOLOGICAL TECH CO stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 2.16 K employees. See our rating of the largest employees — is SHANGHAI HAOHAI BIOLOGICAL TECH CO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI HAOHAI BIOLOGICAL TECH CO technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI HAOHAI BIOLOGICAL TECH CO stock shows the neutral signal. See more of SHANGHAI HAOHAI BIOLOGICAL TECH CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SHANGHAI HAOHAI BIOLOGICAL TECH CO future price: according to them, 6826 price has a max estimate of 124.53 HKD and a min estimate of 103.66 HKD. Read a more detailed SHANGHAI HAOHAI BIOLOGICAL TECH CO forecast: see what analysts think of SHANGHAI HAOHAI BIOLOGICAL TECH CO and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI HAOHAI BIOLOGICAL TECH CO EBITDA is 659.87 M HKD, and current EBITDA margin is 22.63%. See more stats in SHANGHAI HAOHAI BIOLOGICAL TECH CO financial statements.